|
Quotes & Info
|
| DGX > SEC Filings for DGX > Form 8-K on 7-Jan-2013 | All Recent SEC Filings |
7-Jan-2013
Change in Directors or Principal Officers, Financial Statements and Exhibit
(e) On January 1, 2013, Everett Cunningham, Senior Vice President, Commercial, and John B. Haydon, Senior Vice President, Operations, became executive officers of Quest Diagnostics Incorporated (the "Company") and became Schedule B Participants in the Company's Executive Officer Severance Plan (the "Plan"). A copy of the Plan with updated Schedules A and B is attached as Exhibit 10.1 and is incorporated herein by reference.
d. Exhibit Description
10.1 Amended and Restated Quest Diagnostics Incorporated
Executive Officer Severance Plan
|
|